Summary: Latvia’s COVID-19 app connects to the EU interoperability system, the...

Summary: Latvia’s COVID-19 app connects to the EU interoperability system, the...
Summary: Latvia’s COVID-19 app connects to the EU interoperability system, the...
LATVIA’S COVID-19 APP CONNECTS TO THE EU INTEROPERABILITY SYSTEM

The Latvian contact tracing app Apturi Covid (Stop Covid) has connected to the interoperability system for other contact tracing apps in the European Commission.

In this way, the Apturi Covid app can warn and notify a user if they have come into contact with a person infected with COVID-19 in Germany, Italy, Ireland and Spain.

The European Commission’s solution last month enabled the interoperability of contact tracing apps from EU member states.

Smartphones with the app can exchange “digital handshakes” via Bluetooth, which is encrypted on the user’s phone.

MYON LINE THERAPY PARTNER WITH VITALITY

UK virtual psychology clinic My OnlineTherapy has announced a new partnership with life insurance company Vitality to develop mental health support for its health members.

The service, which went online this month, offers members mental health treatments such as cognitive behavioral therapy (CBT), mindfulness-based cognitive therapy, and schema therapy from qualified psychologists delivered digitally via a video conferencing service.

Dr. Keith Klintworth, Group COO and Chief Executive Officer of VitalityHealth, said: “With the life changing pandemic as we know it, there has never been a more important time to maintain our sanity and provide our members with the right support at their disposal Offering wise is a priority for us.

“By partnering with My Online Therapy, Vitality continues to expand our entire package of psychosocial care available to our members, ensuring people get the support and help they need when they need it.”

APP TO HELP NHS PREVENT HOSPITAL DISEASES IN COVID-19

NHS trusts are being offered an app to help reduce hundreds of deaths associated with two hospital-acquired conditions – acute kidney damage (AKI) and pneumonia (HAP).

Known as Compass, the mobile app provides a tool for NHS clinical staff to assess a patient’s risk of developing hospital conditions so that appropriate action can be taken to prevent and prevent significant numbers of AKI and HAP cases Reduce ICU intake.

A study by researchers at Southampton NHS FT University Hospital, conducted between March and May this year, found that AKI was present in 31% of COVID-19 hospitalized patients and that AKI was associated with 27% of ICU admissions.

The app has been approved by the drug and health products regulator and will be made available to NHS hospitals for free for the first 90 days to aid hospitals in the second wave of COVID-19.

L’OREAL SIGNS LICENSE AGREEMENT WITH BIOTECH COMPANY

The Netherlands-based phage and endolysin technology development company, Micreos and L’Oréal, announced that they have signed a license agreement to expand their expertise in biotechnology and the skin microbiome, the community of bacteria and microorganisms that live on the skin , to expand.

Under the agreement, Micreos will give L’Oréal access to its endolysin, a type of active protein in the cosmetic field. With this technology, unwanted bacteria in the skin flora can be combated, which are responsible for various skin problems.

Mark Offerhaus, CEO of Micreos: “We expect this partnership to be groundbreaking. L’Oréal has been a leader in skin care for decades. Micreos is a leader in targeted bacterial biotechnology. We combine our strengths and millions will benefit from it. ”

HOSPITALS ADOPT COVID-19 TECH TO KEEP STAFF SAFE

A new digital tool will be launched for NHS trusts across the UK to improve protection for temporary workers at high risk from COVID-19.

Patchwork Health has developed a digital solution to help hospitals comply with new NHS guidelines for employee risk assessment. With this system, management teams can digitize the risk profiles of their employees and operate a confidential live dashboard that shows whether and when employees at high risk have to work on wards with higher risk.

The technology replaces the process of using spreadsheets to monitor risk factors. The NHS human resources management can ensure that shifts booked by people with known risk factors can be monitored in real time and that alternative shifts can be arranged for employees at high risk.

MENTAL HEALTH NHS TRUST IMPLEMENTED NEW PATIENT FLOW WITH SERVELEC

Servelec, a provider of digital care software, announces that South West London and St. George’s Mental Health NHS Trust, which serves people in five London boroughs, have gone live with the implementation of its patient management solution, Flow.

The product replaced the Trust’s existing patient management processes, where hospitals were manually called for information on bed availability, handwritten notes were made on whiteboards and then entered into the electronic patient record (EPR).

Servelec’s patient flow solution digitizes this process and provides an end-to-end view of the patient journey. Staff at the trust can enter information on a digital touch screen that displays information about all patients on the hospital wards, including status and location.

South West London and St. George’s Mental Health NHS Trust is an existing user of Servelec’s Rio EPR software, which is integrated with Flow.

PORTABLE MEDICAL DEVICE FOR DIAGNOSIS OF SLEEP APNEA

Medical device company Acurable has announced the launch of its first product, AcuPebble SA100, a portable device that enables automated and remote diagnosis of obstructive sleep apnea (OSA).

Diagnosing OSA has traditionally required hospital visits for patients, and physicians had to manually review and analyze data from a patient’s sleep study.

AcuPebble SA100 aims to automate this process and provide a clinically validated diagnosis that is the current gold standard for outpatients. This is particularly important in light of COVID-19 and the NHS transition to digital initial and remote consultations.

AcuPebble SA100 received the CE mark in September 2020.

HULL UNIVERSITY HOSPITALS NHS TRUST EMPLOYED DXC TECH

Hull University Teaching Hospitals NHS Trust has provided the cloud-based mobile app Clinical Aide from DXC Technology. The platform improves secure access to electronic patient records and increases the safety of patients and hospital staff in COVID-19 wards and intensive care units.

Clinical teams can now securely view and use patient information from the Lorenzo EPR, part of the DXC Care Suite, via a tablet or other device using a cloud-based mobile app installed on top of the Trust’s Electronic Health Record System (EPR) Mobile device.

Mobile access to a patient’s documented information is aimed at reducing the need for staff to enter higher risk hospital areas to review and update medical records directly on workstations and the need for paper-based detailed patient information from the COVID-19 of the hospital to transfer guards.

IKTOS COLLABORATION WITH MERCK ON NEW DRUG DESIGN

The AI ​​drug design company Iktos has announced an additional cooperation agreement for new drug design with Germany-based Merck KGaA, Darmstadt, a leading science and technology company, in AI.

In this new collaboration, Iktos’ new generative design technology will be used to facilitate the design of an undisclosed drug discovery program at Merck KGaA, Darmstadt.

Iktos’ generative AI technology is combined with structure-based modeling. Structures are designed iteratively in order to maximize the protein-ligand interaction and to identify novel structures that have already been investigated in the project.

Joern-Peter Halle, Global Head of Research for Healthcare at Merck KGaA, Darmstadt, said: “AI has the potential to improve and accelerate the drug discovery process, which could mean faster access to novel treatment options for patients.”

“This additional collaboration with Iktos shows our commitment to partnerships to access the latest technology and enrich our discovery engine.”

The Scottish Government is giving MED-TECH innovation a funding boost

MIME Technologies, a medical technology spin-out from the University of Aberdeen, has received £ 248,000 funding from the Scottish Government to help deliver technologies that drive new maritime med-tech solutions.

It will also help the hard-hit aviation industry recover from the pandemic.

The company develops technologies to assist non-medical professionals in first-response situations in environments removed from immediate medical care.

The solution from MIME Technologies, originally aimed at the aviation industry, transmits emergency data on site, such as B. the symptoms of a heart attack or stroke, using secure cloud technology to professional medical services.

Providing flight medics with on-site access to this data will enable them to make informed decisions about the passenger’s medical care needs, assist in-flight diversion decisions, and ensure handover to medical care.

These were the details of the news Summary: Latvia’s COVID-19 app connects to the EU interoperability system, the... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at de24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

NEXT FBI director warns that Chinese hackers are preparing to ‘wreak havoc’ on US critical infrastructure